Fragment screening of cyclin G-associated kinase by weak affinity chromatography.
about
A ligand-observed mass spectrometry approach integrated into the fragment based lead discovery pipeline.Targeting Anti-Cancer Active Compounds: Affinity-Based Chromatographic Assays.Analysis of biomolecular interactions using affinity microcolumns: a review.Analysis of Biological Interactions by Affinity Chromatography: Clinical and Pharmaceutical Applications.Selective Inhibitors of Cyclin G Associated Kinase (GAK) as Anti-Hepatitis C Agents.
P2860
Fragment screening of cyclin G-associated kinase by weak affinity chromatography.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Fragment screening of cyclin G-associated kinase by weak affinity chromatography.
@ast
Fragment screening of cyclin G-associated kinase by weak affinity chromatography.
@en
Fragment screening of cyclin G-associated kinase by weak affinity chromatography.
@nl
type
label
Fragment screening of cyclin G-associated kinase by weak affinity chromatography.
@ast
Fragment screening of cyclin G-associated kinase by weak affinity chromatography.
@en
Fragment screening of cyclin G-associated kinase by weak affinity chromatography.
@nl
prefLabel
Fragment screening of cyclin G-associated kinase by weak affinity chromatography.
@ast
Fragment screening of cyclin G-associated kinase by weak affinity chromatography.
@en
Fragment screening of cyclin G-associated kinase by weak affinity chromatography.
@nl
P2860
P1476
Fragment screening of cyclin G-associated kinase by weak affinity chromatography.
@en
P2093
Elinor Meiby
Sten Ohlson
P2860
P2888
P304
P356
10.1007/S00216-012-6335-6
P407
P577
2012-08-24T00:00:00Z